BMED vs THNR: Holdings Overlap & Returns

Over the year to Nov 13, 2026, BMED returned +25.4% to THNR's +6.7%; 20% of their weight is in the same names.

Return gap
+18.7 pts1 year to Nov 13, 2026: BMED ahead, total return
Fee gap
0.04 ptsA year: BMED 0.55%, THNR 0.59%, per filings dated Nov 21, 2025 and Jan 28, 2026
Overlap
20%Share of the two books held in common, holdings dated Nov 12, 2026 and Nov 13, 2026
Net flow
$0k / −$791kBMED / THNR, Oct 13, 2026 to Nov 12, 2026, daily basis
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
BMED and THNR · 1 year

Growth of 100

BMED +25.4%THNR +6.7%
Growth of 100 in BMED and THNR over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. BMED ends at 125.4 (+25.4%), THNR at 106.7 (+6.7%).

BMED +25.4%, THNR +6.7%: BMED +18.7 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

BMED and THNR flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in BMED costs about $11.50 one way and $23.00 in and out, at a median spread of 0.23%. The 0.23% spread is BMED’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in THNR for 10 years at 0.59% a year costs about $972 in fees and lost growth; BMED at 0.55% would cost $908. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

BMED · 1 year to Nov 13, 202642% of its weight is outside the S&P 500
42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 96% · top ten 44% of the fund · 55 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 14% in42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%in the S&P 500outsideactive share 96% · Nasdaq-100: 14% in

58% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.

THNR · 1 year to Nov 13, 202654% of its weight is outside the S&P 500
54% of its weight is outside the S&P 50046% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.46%54%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 97% · top ten 66% of the fund · 21 holdings as published by its issuer for Nov 13, 2026 · Nasdaq-100: 18% in54% of its weight is outside the S&P 50046% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.46%54%in the S&P 500outside the S&P 500active share 97% · Nasdaq-100: 18% in

46% of THNR's weight is in S&P 500 companies and 54% is outside the index. Holdings as of Nov 13, 2026.

Key numbers

BMED in the S&P 500
58.2%
THNR in the S&P 500
45.8%
BMED total return, 1 year
+25.4%
THNR total return, 1 year
+6.7%

BMED costs 0.04 points a year less; their one-year returns differ by 18.7 points; BMED is 2.9 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+25.4%+6.7%
Below its all-time high6.3%, high on Aug 25, 2026
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.55%0.59%
Net assets, as of Nov 12, 2026$15m$5.2m
Holdings in common20%

The numbers behind it

Net assets: $15m on Nov 13, 2026 for iShares Health Innovation Active ETF, and $5.2m on Nov 12, 2026 for Amplify Weight Loss Drug & Treatment ETF.

Holdings in common uses holdings dated Nov 12, 2026 and Nov 13, 2026.

What they share

By the books each fund has filed, BMED and THNR hold 20% of their money in the same securities at the same weight. Holdings dated Nov 12, 2026 and Nov 13, 2026.

0half (50%)100%

half

20% in common

Held in common

Show all 6 holdings
GILEAD SCIENCES5.80%5.66%
ABBVIE4.91%5.65%
MERCK & CO INC2.97%4.98%
ROCHE PS PAR AG2.85%5.68%
AMGEN INC2.57%6.11%
PFIZER1.46%5.24%

Only in BMED

Show all 8 holdings
MODERNA5.52%
DANAHER5.15%
THERMO FISHER SCIENTIFIC4.33%
EDWARDS LIFESCIENCES4.25%
BIOGEN3.70%
METTLER-TOLEDO INTERNATIONAL INC3.61%
IQVIA HOLDINGS INC3.58%
VERTEX PHARMACEUTICALS3.29%

Only in THNR

Show all 8 holdings
Eli Lilly & Co12.10%
Novo Nordisk A/S8.89%
Regeneron Pharmaceuticals Inc6.05%
AstraZeneca PLC5.79%
Chugai Pharmaceutical Co Ltd5.17%
CSPC Pharmaceutical Group Ltd4.44%
Viking Therapeutics Inc4.43%
Innovent Biologics Inc4.35%

Side by side

Open the table
FundiShares Health Innovation Active ETF · Holds 55 stocks in healthcare innovation and GLP-1, 58% of its weight in S&P 500 companiesAmplify Weight Loss Drug & Treatment ETF · Holds 21 stocks in healthcare innovation and GLP-1, 46% of its weight in S&P 500 companies
IssueriSharesAmplify
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50058.2%45.8%
Active share vs the S&P 50095.6%96.5%
In the Nasdaq-10013.8%17.8%
Holdings5521
Top ten, share of the fund44.1%66.3%
Expense ratio0.55%0.59%
Fee for the differing part0.58%0.61%
Total return, 1 year+25.4%+6.7%
vs its benchmarknot measurednot measured
Below its high−2.7%−6.3%
Net assets, BMED as of Nov 13, 2026 and THNR as of Nov 12, 2026$15m$5.2m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+12.9%−0.1%
6 months+33.6%+7.0%
1 year+25.4%+6.7%
3 years+68.1%–
Since launch (Not the same days: BMED Oct 2020 · THNR May 2024)+42.8%+5.6%

– means no data for this window.

About BMED

By weight, 58% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 44% of the fund across 55 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +25.4% with distributions reinvested.

About THNR

By weight, 46% of THNR's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 66% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.

More

Over the year to Nov 13, 2026 the fund returned +6.7% with distributions reinvested. It sits 6.3% below its all-time high of Aug 25, 2026.

20% of the two portfolios are the same securities at the same weight.

Questions people ask

Do BMED and THNR hold the same stocks?

By their latest filings, 20% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BMED or THNR?

BMED has 58% of its weight in S&P 500 names and THNR has 46%, so THNR differs more from the index.

Which is cheaper, BMED or THNR?

BMED charges 0.55% a year and THNR charges 0.59%, so BMED is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, BMED against THNR, data as of Nov 13, 2026. https://etfiq.com/compare/themes/bmed-vs-thnr

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.